{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:45:23Z","timestamp":1780343123501,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ygyno.2010.08.028","type":"journal-article","created":{"date-parts":[[2010,9,18]],"date-time":"2010-09-18T08:27:29Z","timestamp":1284798449000},"page":"462-468","source":"Crossref","is-referenced-by-count":30,"title":["Correlates of the preoperative level of CA125 at presentation of ovarian cancer"],"prefix":"10.1016","volume":"119","author":[{"given":"Daniel W.","family":"Cramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison F.","family":"Vitonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annekathryn","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo R.","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross S.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.08.028_bb0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0090-8258(92)90082-T","article-title":"Serum CA125 regression in epithelial ovarian cancer: correlation with reassessment findings and survival","volume":"47","author":"Buller","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/gyno.1995.1181","article-title":"Serum half-life of CA 125 during early chemotherapy as an independent prognostic variable for patients with advanced epithelial ovarian cancer: results of a multicentric Italian study","volume":"58","author":"Gadducci","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1471-0528.1987.tb02354.x","article-title":"Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence","volume":"94","author":"Schilthuis","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0025","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ygyno.2006.09.028","article-title":"CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish \"MALOVA\" Ovarian Cancer Study","volume":"104","author":"Hogdall","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0029-7844(02)02057-4","article-title":"Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer","volume":"100","author":"Cooper","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0035","first-page":"140","article-title":"Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma","volume":"41","author":"Geisler","year":"1996","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1055-9965.EPI-06-0688","article-title":"Incessant ovulation, mucin 1 immunity, and risk for ovarian cancer","volume":"16","author":"Terry","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0050","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/IGC.0b013e3181a83e04","article-title":"Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: a retrospective analysis and review of the literature","volume":"19","author":"Kolwijck","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0055","first-page":"1002","article-title":"Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis","volume":"79","author":"Makar","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0090-8258(87)80009-4","article-title":"Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma","volume":"28","author":"Zanaboni","year":"1987","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/1097-0142(20001001)89:7<1555::AID-CNCR20>3.0.CO;2-J","article-title":"The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study","volume":"89","author":"Hefler","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/gyno.2002.6800","article-title":"Ascites as a predictor of ovarian malignancy","volume":"87","author":"Shen-Gunther","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0075","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1525-1438.2002.01171.x","article-title":"The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma","volume":"12","author":"Saygili","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1245\/ASO.2003.05.015","article-title":"Cancer antigen 125 associated with multiple benign and malignant pathologies","volume":"10","author":"Miralles","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0085","first-page":"489","article-title":"Factors influencing serum CA125II levels in healthy postmenopausal women","volume":"10","author":"Pauler","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2008.05.006","article-title":"The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial","volume":"110","author":"Johnson","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0095","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<2068::AID-CNCR25>3.0.CO;2-8","article-title":"Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women","volume":"85","author":"Jeyarajah","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/geno.1996.0633","article-title":"Isolation of the murine Nbr1 gene adjacent to the murine Brca1 gene","volume":"38","author":"Chambers","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2006.06.7884","article-title":"Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer","volume":"25","author":"Hermsen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0110","first-page":"428","article-title":"CA 125 levels in menopausal women","volume":"76","author":"Westhoff","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1095\/biolreprod.106.058347","article-title":"MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium: in vitro evidence that MUC16 is a barrier to trophoblast adherence","volume":"78","author":"Gipson","year":"2008","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00000441-198607000-00005","article-title":"Evaluation of serum CA125 values in healthy individuals and pregnant women","volume":"292","author":"Haga","year":"1986","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000293642","article-title":"Lymphocyte subpopulations in mother and newborn: correlation with sex of the newborn and number of pregnancies","volume":"27","author":"Komlos","year":"1989","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/humupd\/1.2.173","article-title":"CA125 and endometriosis","volume":"1","author":"Muyldermans","year":"1995","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0135","doi-asserted-by":"crossref","first-page":"24408","DOI":"10.1002\/jcla.20323","article-title":"Cancer antigen 125 levels in inflammatory bowel diseases","volume":"23","author":"Ataseven","year":"2009","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3109\/02841869709001350","article-title":"Vaginal fluid and serum CEA, CA125 and SCC in normal conditions and in benign and malignant diseases of the genital tract","volume":"36","author":"Sarandakou","year":"1997","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0145","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/bjc.1995.436","article-title":"Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients","volume":"72","author":"Gourevitch","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2010.08.028_bb0150","first-page":"A196","article-title":"Autoantibody signatures and immune complexes as potential biomarkers in ovarian cancer with low serum CA-125","volume":"56","author":"O'Rourke","year":"2010","journal-title":"Clin Chem"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810006220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810006220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T01:23:55Z","timestamp":1544232235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810006220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0090825810006220"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.08.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}